BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32258338)

  • 1. Art of prevention: The importance of measles recognition and vaccination.
    Vassantachart JM; Yeo AH; Vassantachart AY; Jacob SE; Golkar L
    Int J Womens Dermatol; 2020 Mar; 6(2):89-93. PubMed ID: 32258338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May 2006.
    Sheppeard V; Forssman B; Ferson MJ; Moreira C; Campbell-Lloyd S; Dwyer DE; McAnulty JM
    Commun Dis Intell Q Rep; 2009 Mar; 33(1):21-6. PubMed ID: 19618764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination coverage before and after primary health care implementation and trend of target diseases in Al Hassa, Saudi Arabia.
    al Teheawy MM; Foda AM
    J Egypt Public Health Assoc; 1992; 67(1-2):75-86. PubMed ID: 1295951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Reemergence of Measles.
    Abad CL; Safdar N
    Curr Infect Dis Rep; 2015 Dec; 17(12):51. PubMed ID: 26446612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles Vaccine-Associated Rash Illness in China: an Emerging Issue in the Process of Measles Elimination.
    Cui A; Wang H; Zhu Z; Mao N; Song J; Zhang Y; Xu W
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32878947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles: not just another viral exanthem.
    Duke T; Mgone CS
    Lancet; 2003 Mar; 361(9359):763-73. PubMed ID: 12620751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
    Marin M; Nguyen HQ; Langidrik JR; Edwards R; Briand K; Papania MJ; Seward JF; LeBaron CW
    Clin Infect Dis; 2006 Feb; 42(3):315-9. PubMed ID: 16392073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.
    Casabona G; Berton O; Singh T; Knuf M; Bonanni P
    Expert Rev Vaccines; 2023; 22(1):764-776. PubMed ID: 37642012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles: a disease often forgotten but not gone.
    Leung AK; Hon KL; Leong KF; Sergi CM
    Hong Kong Med J; 2018 Oct; 24(5):512-520. PubMed ID: 30245481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles: summary of worldwide impact.
    Assaad F
    Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of single-component measles vaccine in school children.
    Tosun S; Olut AI; Tansug N
    Vaccine; 2017 Dec; 35(52):7309-7311. PubMed ID: 29128384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Progression, Clinical Features, and Risk Factors for Pneumonia in Unvaccinated Children and Adolescents with Measles: A Re-Emerging Disease in Romania.
    Turaiche M; Grigoras ML; Bratosin F; Bogdan I; Bota AV; Cerbu B; Gurban CV; Wulandari PH; Gurumurthy S; Hemaswini K; Citu C; Marincu I
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles: taking steps forward to prevent going backwards.
    Gupta K; Chen M; Rocker J
    Curr Opin Pediatr; 2020 Jun; 32(3):436-445. PubMed ID: 32374581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles clinical presentation, hospitalization and vaccination status among children in a community-wide outbreak.
    Stein-Zamir C; Shoob H; Abramson D
    Vaccine; 2023 Apr; 41(17):2764-2768. PubMed ID: 37002179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.